192 related articles for article (PubMed ID: 35078445)
1. Bioinformatics screening the novel and promising targets of curcumin in hepatocellular carcinoma chemotherapy and prognosis.
Yang T; Chen Y; Xu J; Li J; Liu H; Liu N
BMC Complement Med Ther; 2022 Jan; 22(1):21. PubMed ID: 35078445
[TBL] [Abstract][Full Text] [Related]
2. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
3. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
5. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
6. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract][Full Text] [Related]
7. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
Sun Q; Liu P; Long B; Zhu Y; Liu T
Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
Zhang Y; Tang Y; Guo C; Li G
Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
[TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
10. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract][Full Text] [Related]
11. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
12. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches.
Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Shao M; Luo Y; Zhu Y
Cancer Biomark; 2018; 22(3):511-521. PubMed ID: 29843214
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis.
Meng Z; Wu J; Liu X; Zhou W; Ni M; Liu S; Guo S; Jia S; Zhang J
J Int Med Res; 2020 Jul; 48(7):300060520910019. PubMed ID: 32722976
[TBL] [Abstract][Full Text] [Related]
14. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
15. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
16. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
[TBL] [Abstract][Full Text] [Related]
17. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
18. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
19. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang WX; Pan YY; You CG
Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
